NO20034661D0 - Nociceptin-analoger - Google Patents
Nociceptin-analogerInfo
- Publication number
- NO20034661D0 NO20034661D0 NO20034661A NO20034661A NO20034661D0 NO 20034661 D0 NO20034661 D0 NO 20034661D0 NO 20034661 A NO20034661 A NO 20034661A NO 20034661 A NO20034661 A NO 20034661A NO 20034661 D0 NO20034661 D0 NO 20034661D0
- Authority
- NO
- Norway
- Prior art keywords
- nociceptin
- analogues
- nociceptin analogues
- orl1
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Finishing Walls (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28466601P | 2001-04-18 | 2001-04-18 | |
US28466801P | 2001-04-18 | 2001-04-18 | |
US28466701P | 2001-04-18 | 2001-04-18 | |
US28466901P | 2001-04-18 | 2001-04-18 | |
PCT/US2002/012351 WO2002085357A1 (en) | 2001-04-18 | 2002-04-18 | Nociceptin analogs |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20034661D0 true NO20034661D0 (no) | 2003-10-17 |
NO20034661L NO20034661L (no) | 2003-12-17 |
Family
ID=27501377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20034661A NO20034661L (no) | 2001-04-18 | 2003-10-17 | Nociceptin-analoger |
Country Status (26)
Country | Link |
---|---|
US (4) | US6867222B2 (no) |
EP (7) | EP1598339B1 (no) |
JP (4) | JP4364513B2 (no) |
KR (2) | KR100878774B1 (no) |
CN (1) | CN100352816C (no) |
AT (4) | ATE434607T1 (no) |
AU (1) | AU2002307416B2 (no) |
BR (1) | BR0209129A (no) |
CA (1) | CA2444198C (no) |
CL (2) | CL2009001279A1 (no) |
CY (4) | CY1108707T1 (no) |
CZ (1) | CZ20032850A3 (no) |
DE (4) | DE60231442D1 (no) |
DK (4) | DK1379246T3 (no) |
ES (4) | ES2322158T3 (no) |
HK (4) | HK1063149A1 (no) |
HU (1) | HUP0401109A3 (no) |
IL (4) | IL158484A0 (no) |
MX (1) | MXPA03009600A (no) |
NO (1) | NO20034661L (no) |
NZ (5) | NZ540235A (no) |
PL (1) | PL367310A1 (no) |
PT (4) | PT1598340E (no) |
SI (4) | SI1379246T1 (no) |
WO (1) | WO2002085357A1 (no) |
YU (1) | YU82303A (no) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6615189B1 (en) * | 1998-06-22 | 2003-09-02 | Bank One, Delaware, National Association | Debit purchasing of stored value card for use by and/or delivery to others |
NZ540235A (en) | 2001-04-18 | 2007-01-26 | Euro Celtique Sa | Nociceptin analogs for the treatment of pain |
DE10252665A1 (de) | 2002-11-11 | 2004-06-03 | Grünenthal GmbH | 4-Aminomethyl-1-aryl-cyclohexylamin-Derivate |
WO2004064835A1 (en) * | 2003-01-17 | 2004-08-05 | Neurosearch A/S | Use of ion channel modulating agents for treating pain |
EP1608639A2 (en) | 2003-02-28 | 2005-12-28 | Bayer Pharmaceuticals Corporation | Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
US20050228023A1 (en) * | 2003-12-19 | 2005-10-13 | Sri International | Agonist and antagonist ligands of the nociceptin receptor |
CA2555219A1 (en) * | 2004-02-03 | 2005-08-18 | R. Richard Goehring | Synthesis of cyanoimino-benzoimidazoles |
US20090181948A1 (en) * | 2005-01-31 | 2009-07-16 | Kyowa Hakko Kogyo Co., Ltd. | Diamine derivative |
DE602006006463D1 (de) * | 2005-09-30 | 2009-06-04 | Hoffmann La Roche | Indanderivate als antagonisten des mch-rezeptors |
EP1983992A4 (en) * | 2006-01-19 | 2010-08-18 | Abbott Lab | 2-IMINO-BENZIMIDAZOLES |
EP1987009A1 (en) * | 2006-01-30 | 2008-11-05 | Euro-Celtique S.A. | Cyclourea compounds as calcium channel blockers |
TW200813018A (en) | 2006-06-09 | 2008-03-16 | Astrazeneca Ab | Novel compounds |
US20080051380A1 (en) | 2006-08-25 | 2008-02-28 | Auerbach Alan H | Methods and compositions for treating cancer |
US20080287479A1 (en) * | 2006-12-20 | 2008-11-20 | Pfizer Inc | Inhibitors of serine palmitoyltransferase |
CN101595100B (zh) * | 2007-01-16 | 2014-06-11 | 普渡制药公司 | 作为orl-1配体的杂环取代的哌啶 |
US8877779B2 (en) * | 2007-03-01 | 2014-11-04 | Mitsubishi Tanabe Pharma Corporation | Benzimidazole compound and pharmaceutical use thereof |
WO2009027820A2 (en) | 2007-08-31 | 2009-03-05 | Purdue Pharma L.P. | Substituted-quinoxaline-type-piperidine compounds and the uses thereof |
WO2009040067A2 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
US8119661B2 (en) | 2007-09-11 | 2012-02-21 | Astrazeneca Ab | Piperidine derivatives and their use as muscarinic receptor modulators |
US8697722B2 (en) | 2007-11-02 | 2014-04-15 | Sri International | Nicotinic acetylcholine receptor modulators |
PT2324013E (pt) | 2008-07-21 | 2012-12-24 | Purdue Pharma Lp | Compostos de piperidina ligados por pontes do tipo de quinoxalina substituída e as respectivas utilizações |
GB0817982D0 (en) | 2008-10-01 | 2008-11-05 | Glaxo Group Ltd | Compounds |
CN102905527B (zh) | 2010-01-11 | 2016-08-24 | 阿斯特来亚治疗有限责任公司 | 烟碱型乙酰胆碱受体调节剂 |
AU2012328561A1 (en) | 2011-10-28 | 2014-04-17 | Merck Sharp & Dohme Corp. | Benzoxazolinone compounds with selective activity in voltage-gated sodium channels |
TW201348231A (zh) * | 2012-02-29 | 2013-12-01 | Amgen Inc | 雜雙環化合物 |
US9963458B2 (en) | 2012-12-27 | 2018-05-08 | Purdue Pharma L.P. | Indole and indoline-type piperidine compounds and uses thereof |
WO2014102590A1 (en) | 2012-12-27 | 2014-07-03 | Purdue Pharma L.P. | Substituted piperidin-4-amino-type compounds and uses thereof |
US9090618B2 (en) | 2012-12-27 | 2015-07-28 | Purdue Pharma L.P. | Substituted benzimidazole-type piperidine compounds and uses thereof |
US9951038B2 (en) | 2012-12-27 | 2018-04-24 | Purdue Pharma L.P. | Quinazolin-4(3H)-one-type piperidine compounds and uses thereof |
US9884844B2 (en) | 2012-12-31 | 2018-02-06 | Sunovion Pharmaceuticals, Inc. | Heterocyclic compounds and methods of use thereof |
US10112924B2 (en) * | 2015-12-02 | 2018-10-30 | Astraea Therapeutics, Inc. | Piperdinyl nociceptin receptor compounds |
EP3383390A4 (en) | 2015-12-02 | 2019-11-20 | Astraea Therapeutics, LLC | PIPERIDINYL COMPOUNDS FOR NOCICEPTIN RECEPTOR |
JP2019522032A (ja) | 2016-07-29 | 2019-08-08 | ヤンセン ファーマシューティカ エヌ.ベー. | 前立腺癌の治療方法 |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US49212A (en) * | 1865-08-08 | Improvement in submerged force-pumps | ||
US171360A (en) * | 1875-12-21 | Improvement in mortising-machines | ||
US3161645A (en) | 1962-12-18 | 1964-12-15 | Res Lab Dr C Janssen N V | 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds |
US3318900A (en) | 1964-05-06 | 1967-05-09 | Janssen Pharmaceutica Nv | Derivatives of benzimidazolinyl piperidine |
US3325499A (en) * | 1964-11-02 | 1967-06-13 | Mcneilab Inc | 1-(1-hydrocarbyl-4-piperdyl)-2-indolinone |
US3325490A (en) * | 1965-02-23 | 1967-06-13 | Rexall Drug Chemical | Substituted 1-hydroxydibenzopyrans |
DE2609645A1 (de) * | 1976-03-09 | 1977-09-15 | Boehringer Sohn Ingelheim | Aminoalkylheterocyclen |
DE3066434D1 (en) | 1979-11-21 | 1984-03-08 | Kyowa Hakko Kogyo Kk | Novel piperidine derivatives, method for the preparation thereof and pharmaceutical compositions containing them |
US4329353A (en) | 1980-10-22 | 1982-05-11 | Janssen Pharmaceutica, N.V. | 1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof |
US4410528A (en) * | 1980-05-16 | 1983-10-18 | Kyowa Hakko Kogyo Co., Ltd. | Hypotensive piperidine derivatives |
JPS58180481A (ja) | 1982-04-15 | 1983-10-21 | Kyowa Hakko Kogyo Co Ltd | 新規なピペリジン誘導体 |
JPS60120872A (ja) | 1983-12-01 | 1985-06-28 | Kyowa Hakko Kogyo Co Ltd | 新規なヘテロ環状化合物及び強心剤 |
DE3827641A1 (de) * | 1988-08-16 | 1990-03-08 | Basf Ag | 2,6-polyalkylpiperidinsubstituierte bislactame und deren verwendung zum stabilisieren von organischem material, insbesondere von kunststoffen und damit stabilisiertes material |
DE4332168A1 (de) * | 1993-02-22 | 1995-03-23 | Thomae Gmbh Dr K | Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
AU691829B2 (en) * | 1993-07-16 | 1998-05-28 | Merck & Co., Inc. | Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
FR2708608B1 (fr) * | 1993-07-30 | 1995-10-27 | Sanofi Sa | Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant. |
GB9325074D0 (en) | 1993-12-07 | 1994-02-02 | Zeneca Ltd | Bicyclic heterocycles |
WO1995028397A1 (en) * | 1994-04-14 | 1995-10-26 | Merck & Co., Inc. | Alpha1c adrenergic receptor antagonists |
FR2722190B1 (fr) * | 1994-07-05 | 1996-10-04 | Sanofi Sa | Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant |
AU3192295A (en) * | 1994-08-11 | 1996-03-07 | Yamanouchi Pharmaceutical Co., Ltd. | Substituted amine derivative and medicinal composition containing the same |
US5767118A (en) | 1994-10-26 | 1998-06-16 | Merck & Co., Inc. | 4-Heterocyclic peperidines promote release of growth hormone |
US5574044A (en) | 1994-10-27 | 1996-11-12 | Merck & Co., Inc. | Muscarine antagonists |
WO1996013262A1 (en) * | 1994-10-27 | 1996-05-09 | Merck & Co., Inc. | Muscarine antagonists |
US5576321A (en) * | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
US5789402A (en) * | 1995-01-17 | 1998-08-04 | Eli Lilly Company | Compounds having effects on serotonin-related systems |
GB9603457D0 (no) * | 1996-02-19 | 1996-04-17 | Merck & Co Inc | |
HRP960159A2 (en) * | 1995-04-21 | 1997-08-31 | Bayer Ag | Benzocyclopentane oxazolidinones containing heteroatoms |
US6136839A (en) | 1995-06-12 | 2000-10-24 | G. D. Searle & Co. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
CA2231773A1 (en) | 1995-09-13 | 1997-03-20 | Shigeru Aono | Phenylpiperidine derivative |
ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
CA2250250A1 (en) * | 1996-03-30 | 1997-10-09 | Boehringer Mannheim Gmbh | Novel oxazolidine derivatives, process for their production and medicaments containing them |
JP2001519766A (ja) * | 1996-04-03 | 2001-10-23 | メルク エンド カンパニー インコーポレーテッド | ファルネシルタンパク質トランスフェラーゼの阻害剤 |
US5891889A (en) * | 1996-04-03 | 1999-04-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US6180649B1 (en) | 1996-04-19 | 2001-01-30 | Nerosearch A/S | 1-(4-piperidyl)-benzimidazoles having neurotrophic activity |
BR9712023A (pt) * | 1996-09-10 | 1999-08-31 | Thomae Gmbh Dr K | Aminoácidos derivados, medicamentos contendo esses compostos e processos para a sua preparação. |
US5977134A (en) | 1996-12-05 | 1999-11-02 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
CA2278504A1 (en) | 1997-01-23 | 1998-07-30 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
US6117973A (en) * | 1997-02-24 | 2000-09-12 | Georgia Tech Research Corp. | PNA monomers with electron donor or acceptor |
TWI242011B (en) * | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
US6063796A (en) * | 1997-04-04 | 2000-05-16 | Merck & Co., Inc. | Somatostatin agonists |
JP4366532B2 (ja) | 1997-05-30 | 2009-11-18 | 萬有製薬株式会社 | 2−オキソイミダゾール誘導体 |
JPH10330377A (ja) * | 1997-06-02 | 1998-12-15 | Kyowa Hakko Kogyo Co Ltd | ピペリジン誘導体 |
US6166037A (en) | 1997-08-28 | 2000-12-26 | Merck & Co., Inc. | Pyrrolidine and piperidine modulators of chemokine receptor activity |
JP2001526178A (ja) * | 1997-08-28 | 2001-12-18 | メルク エンド カムパニー インコーポレーテッド | ピロリジン系およびピペリジン系ケモカイン受容体活性調節剤 |
EP0921125B1 (en) | 1997-12-05 | 2002-01-30 | F. Hoffmann-La Roche Ag | 1,3,8-Triazaspiro[4,5]decan-4-on derivatives |
US6166209A (en) | 1997-12-11 | 2000-12-26 | Hoffmann-La Roche Inc. | Piperidine derivatives |
WO1999032481A1 (en) | 1997-12-23 | 1999-07-01 | Alcon Laboratories, Inc. | Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions |
EA200000683A1 (ru) * | 1998-01-19 | 2000-12-25 | Пфайзер Инк. | Производные ряда 4-(2-кето-1-бензимидазолинил)пиперидина в качестве агонистов orl1-рецептора |
WO1999037304A1 (en) | 1998-01-27 | 1999-07-29 | Aventis Pharmaceuticals Products Inc. | SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS |
ID26099A (id) | 1998-03-26 | 2000-11-23 | Japan Tobacco Inc | Turunan amida dan antagonis nosiseptin |
JP2002515503A (ja) | 1998-05-18 | 2002-05-28 | ノボ ノルディスク アクティーゼルスカブ | オピオイド受容体のサブタイプへの高い親和性を有する新規1,3,8−トリアザスピロ〔4,5〕デカノン |
US6262066B1 (en) | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
ID29137A (id) * | 1998-07-27 | 2001-08-02 | Schering Corp | Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1 |
MA26659A1 (fr) * | 1998-08-06 | 2004-12-20 | Pfizer | Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation. |
AU6018799A (en) | 1998-09-09 | 2000-03-27 | Ishihara Sangyo Kaisha Ltd. | Fused-benzene derivatives useful as herbicides |
ES2226493T3 (es) | 1998-12-23 | 2005-03-16 | Schering Corporation | Oximas e hidrazonas sustituidas como antagonistas de neroquinina. |
US6204265B1 (en) * | 1998-12-23 | 2001-03-20 | Schering Corporation | Substituted oximes and hydrazones as neurokinin antagonists |
WO2000038720A1 (fr) * | 1998-12-24 | 2000-07-06 | Meiji Seika Kaisha, Ltd. | Remedes contre la douleur |
JP4011819B2 (ja) * | 1999-04-12 | 2007-11-21 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | インドール誘導体の製造法およびその中間体 |
CN1158258C (zh) | 1999-06-24 | 2004-07-21 | 东丽株式会社 | 肾上腺素能α1B受体拮抗药 |
US6340681B1 (en) | 1999-07-16 | 2002-01-22 | Pfizer Inc | 2-benzimidazolylamine compounds as ORL-1-receptor agonists |
CN1374952A (zh) * | 1999-07-21 | 2002-10-16 | 藤泽药品工业株式会社 | 苯并咪唑酮衍生物及其作为磷酸二酯酶抑制剂的用途 |
JP2003524634A (ja) * | 1999-12-06 | 2003-08-19 | ユーロ−セルティーク,エス.エイ. | ノシセプチン受容体親和性を有するベンズイミダゾール化合物 |
SE9904652D0 (sv) * | 1999-12-17 | 1999-12-17 | Astra Pharma Prod | Novel Compounds |
ES2249237T3 (es) | 2000-01-05 | 2006-04-01 | Pfizer Inc. | Compuestos de bencimidazol como antagonistas del receptor orl1. |
ATE302184T1 (de) * | 2000-02-18 | 2005-09-15 | Meiji Seika Kaisha | Phenoxyalkylaminderivate als agonisten des opioid-delta rezeptors |
AU2001238690A1 (en) * | 2000-03-14 | 2001-09-24 | Sepracor, Inc. | 3-substituted piperidines comprising urea functionality, and methods of use thereof |
US6790854B2 (en) * | 2000-03-24 | 2004-09-14 | Meiji Seika Kaisha, Ltd. | Diphenylalkylamine derivatives useful as opioid receptor agonists |
WO2001092207A1 (fr) | 2000-05-29 | 2001-12-06 | Chugai Seiyaku Kabushiki Kaisha | Procede de production de composes azotes |
EP1167969A2 (en) | 2000-06-14 | 2002-01-02 | Pfizer Inc. | Method and system for predicting pharmacokinetic properties |
EP1309593B1 (en) * | 2000-08-14 | 2006-03-15 | Ortho-McNeil Pharmaceutical, Inc. | Substituted pyrazoles |
PL365606A1 (en) * | 2000-09-06 | 2005-01-10 | Ortho Mcneil Pharmaceutical, Inc. | A method for treating allergies using substituted pyrazoles |
US20040267010A1 (en) * | 2001-02-02 | 2004-12-30 | Forbes Ian Thomson | Sulfonamide compounds, their preparation and use |
AR035230A1 (es) * | 2001-03-19 | 2004-05-05 | Astrazeneca Ab | Compuestos de bencimidazol, proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion farmaceutica, y usos de estos compuestos para la elaboracion de medicamentos |
NZ540235A (en) * | 2001-04-18 | 2007-01-26 | Euro Celtique Sa | Nociceptin analogs for the treatment of pain |
EP1391456B1 (en) | 2001-04-19 | 2009-07-22 | Eisai R&D Management Co., Ltd. | 2-iminoimidazole derivatives |
GEP20084300B (en) | 2001-10-22 | 2008-02-11 | Pfizer Prod Inc | 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
US7244744B2 (en) | 2001-11-01 | 2007-07-17 | Icagen, Inc. | Piperidines |
-
2002
- 2002-04-18 NZ NZ540235A patent/NZ540235A/en unknown
- 2002-04-18 ES ES05014115T patent/ES2322158T3/es not_active Expired - Lifetime
- 2002-04-18 HU HU0401109A patent/HUP0401109A3/hu unknown
- 2002-04-18 DE DE60231442T patent/DE60231442D1/de not_active Expired - Lifetime
- 2002-04-18 KR KR1020067024967A patent/KR100878774B1/ko not_active IP Right Cessation
- 2002-04-18 DK DK02764236T patent/DK1379246T3/da active
- 2002-04-18 BR BR0209129-1A patent/BR0209129A/pt not_active IP Right Cessation
- 2002-04-18 AT AT05014116T patent/ATE434607T1/de not_active IP Right Cessation
- 2002-04-18 DK DK05014115.9T patent/DK1598338T5/da active
- 2002-04-18 PT PT05014117T patent/PT1598340E/pt unknown
- 2002-04-18 NZ NZ551453A patent/NZ551453A/en unknown
- 2002-04-18 SI SI200230780T patent/SI1379246T1/sl unknown
- 2002-04-18 AT AT02764236T patent/ATE410165T1/de active
- 2002-04-18 AT AT05014115T patent/ATE423098T1/de active
- 2002-04-18 DE DE60232752T patent/DE60232752D1/de not_active Expired - Lifetime
- 2002-04-18 CZ CZ20032850A patent/CZ20032850A3/cs unknown
- 2002-04-18 CA CA2444198A patent/CA2444198C/en not_active Expired - Fee Related
- 2002-04-18 PT PT02764236T patent/PT1379246E/pt unknown
- 2002-04-18 EP EP05014116A patent/EP1598339B1/en not_active Expired - Lifetime
- 2002-04-18 SI SI200230819T patent/SI1598340T1/sl unknown
- 2002-04-18 EP EP05014117A patent/EP1598340B1/en not_active Expired - Lifetime
- 2002-04-18 NZ NZ528977A patent/NZ528977A/en not_active IP Right Cessation
- 2002-04-18 EP EP08172606A patent/EP2050450A1/en not_active Withdrawn
- 2002-04-18 MX MXPA03009600A patent/MXPA03009600A/es active IP Right Grant
- 2002-04-18 WO PCT/US2002/012351 patent/WO2002085357A1/en active Application Filing
- 2002-04-18 NZ NZ540234A patent/NZ540234A/en not_active IP Right Cessation
- 2002-04-18 CN CNB028121694A patent/CN100352816C/zh not_active Expired - Fee Related
- 2002-04-18 PT PT05014115T patent/PT1598338E/pt unknown
- 2002-04-18 NZ NZ540233A patent/NZ540233A/en not_active IP Right Cessation
- 2002-04-18 DK DK05014117T patent/DK1598340T3/da active
- 2002-04-18 DE DE60231257T patent/DE60231257D1/de not_active Expired - Lifetime
- 2002-04-18 AU AU2002307416A patent/AU2002307416B2/en not_active Ceased
- 2002-04-18 AT AT05014117T patent/ATE424385T1/de active
- 2002-04-18 ES ES05014116T patent/ES2329252T3/es not_active Expired - Lifetime
- 2002-04-18 ES ES02764236T patent/ES2315394T3/es not_active Expired - Lifetime
- 2002-04-18 SI SI200230847T patent/SI1598339T1/sl unknown
- 2002-04-18 US US10/126,471 patent/US6867222B2/en not_active Expired - Lifetime
- 2002-04-18 IL IL15848402A patent/IL158484A0/xx unknown
- 2002-04-18 EP EP08150837A patent/EP1930322A1/en not_active Withdrawn
- 2002-04-18 YU YU82303A patent/YU82303A/sh unknown
- 2002-04-18 DE DE60229224T patent/DE60229224D1/de not_active Expired - Lifetime
- 2002-04-18 ES ES05014117T patent/ES2323876T3/es not_active Expired - Lifetime
- 2002-04-18 DK DK05014116T patent/DK1598339T3/da active
- 2002-04-18 PT PT05014116T patent/PT1598339E/pt unknown
- 2002-04-18 SI SI200230811T patent/SI1598338T1/sl unknown
- 2002-04-18 KR KR1020037013822A patent/KR100847296B1/ko not_active IP Right Cessation
- 2002-04-18 PL PL02367310A patent/PL367310A1/xx not_active Application Discontinuation
- 2002-04-18 EP EP08150838A patent/EP1918279A3/en not_active Withdrawn
- 2002-04-18 JP JP2002582930A patent/JP4364513B2/ja not_active Expired - Fee Related
- 2002-04-18 EP EP05014115A patent/EP1598338B9/en not_active Expired - Lifetime
- 2002-04-18 EP EP02764236A patent/EP1379246B1/en not_active Expired - Lifetime
-
2003
- 2003-10-17 NO NO20034661A patent/NO20034661L/no not_active Application Discontinuation
- 2003-10-19 IL IL158484A patent/IL158484A/en not_active IP Right Cessation
-
2004
- 2004-07-13 HK HK04105109.3A patent/HK1063149A1/xx not_active IP Right Cessation
- 2004-07-13 HK HK06105728.2A patent/HK1088891A1/xx not_active IP Right Cessation
- 2004-07-13 HK HK06105934.2A patent/HK1088892A1/xx not_active IP Right Cessation
- 2004-07-13 HK HK06104415.3A patent/HK1086000A1/xx not_active IP Right Cessation
-
2005
- 2005-01-11 US US11/032,955 patent/US7495109B2/en not_active Expired - Fee Related
-
2009
- 2009-01-08 CY CY20091100010T patent/CY1108707T1/el unknown
- 2009-02-23 US US12/390,683 patent/US7939670B2/en not_active Expired - Lifetime
- 2009-04-29 CY CY20091100475T patent/CY1109053T1/el unknown
- 2009-05-22 CY CY20091100552T patent/CY1109092T1/el unknown
- 2009-05-25 CL CL2009001279A patent/CL2009001279A1/es unknown
- 2009-05-25 CL CL2009001278A patent/CL2009001278A1/es unknown
- 2009-06-24 JP JP2009150369A patent/JP5189562B2/ja not_active Expired - Fee Related
- 2009-06-24 JP JP2009150368A patent/JP5081870B2/ja not_active Expired - Fee Related
- 2009-06-24 JP JP2009150370A patent/JP2009263380A/ja active Pending
- 2009-09-10 CY CY20091100940T patent/CY1109352T1/el unknown
-
2010
- 2010-10-24 IL IL208903A patent/IL208903A/en not_active IP Right Cessation
- 2010-10-24 IL IL208907A patent/IL208907A/en not_active IP Right Cessation
-
2011
- 2011-03-18 US US13/051,629 patent/US8252815B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20034661D0 (no) | Nociceptin-analoger | |
BR0205721A (pt) | Formulações de oximorfona de liberação controlada | |
CY1108738T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για την αγωγη του πονου | |
DE60231295D1 (de) | R und ppar modulatoren | |
ATE302775T1 (de) | Carbolinderivate | |
FI20010019A (fi) | Menetelmä atrofisen diagnostisoimiseksi | |
DK1694318T3 (da) | (S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum | |
ATE346067T1 (de) | Carbolinderivate | |
NO20054476L (no) | Forbindelser for behandling av smerte | |
NO20045554L (no) | Fremgangsmate for behandling av diabetes | |
BRPI0409376A (pt) | derivados de indeno como agentes farmacêuticos | |
NO20033804L (no) | Karbamatforbindelser for behandling av smerte | |
SV2003000981A (es) | Fenil-heterociclil-eteres ref. pcs10973 | |
SE0101082D0 (sv) | Novel use | |
GB0328295D0 (en) | Therapeutic compounds | |
DK1485352T3 (da) | Aza-spiroforbindelser til behandling af smerter | |
ITMI20022723A1 (it) | Composizioni per il trattamento della sindrome post-menopausa. | |
ITTO20010736A0 (it) | Dispositivo portatile per il trattamento di tessuti organici medianteradiazioni laser. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |